• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-ATP5A1

ATP5A1 Monoclonal Antibody for WB, IHC, IF/ICC, IP, Indirect ELISA

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

Humain, rat, singe, souris

Applications

WB, IHC, IF/ICC, IP, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1B10H3

N° de cat : 66037-1-PBS

Synonymes

1B10H3, ATP synthase F1 subunit alpha, ATP5A, ATP5A 1



Informations sur le produit

66037-1-PBS cible ATP5A1 dans les applications de WB, IHC, IF/ICC, IP, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, singe, souris

Réactivité Humain, rat, singe, souris
Hôte / Isotype Mouse / IgG2b
Clonalité Monoclonal
Type Anticorps
Immunogène ATP5A1 Protéine recombinante Ag8119
Nom complet ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
Masse moléculaire calculée 60 kDa
Poids moléculaire observé 50 kDa
Numéro d’acquisition GenBankBC064562
Symbole du gène ATP5A1
Identification du gène (NCBI) 498
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

The ATP5A1 gene encodes the α subunit of mitochondrial ATP synthase which produces ATP from ADP in the presence of a proton gradient across the membrane. The mitochondrial ATP synthase, also known as Complex V or F1F0 ATP synthase, is a multi-subunit enzyme complex consisting of two functional domains, the F1-containing the catalytic core and the Fo- containing the membrane proton channel. F0 domain has 10 subunits: a, b, c, d, e, f, g, OSCP, A6L, and F6. F1 is composed of subunits α, β, γ, δ, ε, and a loosely attached inhibitor protein IF1. Recently defect in ATP5A1 has been linked to the fatal neonatal mitochondrial encephalopathy. ATP5A1 is localized in the mitochondria and anti-ATP5A1 can be used as the loading control for mitochondrial or Complex V proteins. This antibody recognizes the endogenous ATP5A1 protein in lysates from various cell lines and tissues. The predicted MW of ATP5A1 is 60 kDa, while it undergoes the transit peptide cleavage to become a mature form around 50-55 kDa. Several isoforms of ATP5A1 exist due to the alternative splicing.

{{ptg:RelatedPrimaryAntibodies}}